OIRA Conclusion of EO 12866 Regulatory Review

RIN: 0910-ZB41         View EO 12866 Meetings	Received Date: 11/17/2022
Title: Homeopathic Drug Products; Guidance for Food and Drug Administration Staff and Industry
Agency/Subagency: HHS / FDA	Stage: Notice
Concluded Action: Consistent without Change	Concluded Date: 11/28/2022
Legal Deadline: None	Economically Significant: No
Publication Date:	Unfunded Mandates: No
Major: No	Related To Homeland Security: No
Regulatory Flexibility Analysis Required: No	Small Entities Affected: No
Federalism Implications: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
International Impacts: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No
Pandemic Response: No